Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy

L. M. van Roozendaal; B. Goorts; M. Klinkert; K. B. M. I. Keymeulen; B. de Vries; L. J. A. Strobbe; C. A. P. Wauters; Y. E. van Riet; E. Degreef; E. J. T. Rutgers; J. Wesseling; M. L. Smidt

doi:10.1007/s10549-016-3783-2

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy

L. M. van Roozendaal, B. Goorts^*, M. Klinkert, K. B. M. I. Keymeulen, B. de Vries, L. J. A. Strobbe, C. A. P. Wauters, Y. E. van Riet, E. Degreef, E. J. T. Rutgers, J. Wesseling, M. L. Smidt

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	517-525
Journal	Breast Cancer Research and Treatment
Volume	156
Issue number	3
DOIs	https://doi.org/10.1007/s10549-016-3783-2
Publication status	Published - Apr 2016

Keywords

DCIS
Sentinel lymph node biopsy
Incidence
Treatment

Access to Document

10.1007/s10549-016-3783-2

Cite this

van Roozendaal, L. M., Goorts, B., Klinkert, M., Keymeulen, K. B. M. I., de Vries, B., Strobbe, L. J. A., Wauters, C. A. P., van Riet, Y. E., Degreef, E., Rutgers, E. J. T., Wesseling, J., & Smidt, M. L. (2016). Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy. Breast Cancer Research and Treatment, 156(3), 517-525. https://doi.org/10.1007/s10549-016-3783-2

van Roozendaal, L. M. ; Goorts, B. ; Klinkert, M. ; Keymeulen, K. B. M. I. ; de Vries, B. ; Strobbe, L. J. A. ; Wauters, C. A. P. ; van Riet, Y. E. ; Degreef, E. ; Rutgers, E. J. T. ; Wesseling, J. ; Smidt, M. L. / Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy. In: Breast Cancer Research and Treatment. 2016 ; Vol. 156, No. 3. pp. 517-525.

@article{d21b8a6838e744c58ce0e3040d3607e4,

title = "Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy",

keywords = "DCIS, Sentinel lymph node biopsy, Incidence, Treatment",

author = "{van Roozendaal}, {L. M.} and B. Goorts and M. Klinkert and Keymeulen, {K. B. M. I.} and {de Vries}, B. and Strobbe, {L. J. A.} and Wauters, {C. A. P.} and {van Riet}, {Y. E.} and E. Degreef and Rutgers, {E. J. T.} and J. Wesseling and Smidt, {M. L.}",

year = "2016",

month = apr,

doi = "10.1007/s10549-016-3783-2",

language = "English",

volume = "156",

pages = "517--525",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer, Cham",

number = "3",

}

van Roozendaal, LM, Goorts, B, Klinkert, M, Keymeulen, KBMI, de Vries, B, Strobbe, LJA, Wauters, CAP, van Riet, YE, Degreef, E, Rutgers, EJT, Wesseling, J & Smidt, ML 2016, 'Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy', Breast Cancer Research and Treatment, vol. 156, no. 3, pp. 517-525. https://doi.org/10.1007/s10549-016-3783-2

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy. / van Roozendaal, L. M.; Goorts, B.; Klinkert, M.; Keymeulen, K. B. M. I.; de Vries, B.; Strobbe, L. J. A.; Wauters, C. A. P.; van Riet, Y. E.; Degreef, E.; Rutgers, E. J. T.; Wesseling, J.; Smidt, M. L.

In: Breast Cancer Research and Treatment, Vol. 156, No. 3, 04.2016, p. 517-525.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy

AU - van Roozendaal, L. M.

AU - Goorts, B.

AU - Klinkert, M.

AU - Keymeulen, K. B. M. I.

AU - de Vries, B.

AU - Strobbe, L. J. A.

AU - Wauters, C. A. P.

AU - van Riet, Y. E.

AU - Degreef, E.

AU - Rutgers, E. J. T.

AU - Wesseling, J.

AU - Smidt, M. L.

PY - 2016/4

Y1 - 2016/4

KW - DCIS

KW - Sentinel lymph node biopsy

KW - Incidence

KW - Treatment

U2 - 10.1007/s10549-016-3783-2

DO - 10.1007/s10549-016-3783-2

M3 - Article

C2 - 27083179

VL - 156

SP - 517

EP - 525

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -